Navigating the Evolving Treatment Landscape in HER2-mutated NSCLC - Episode 9
The panel offers comprehensive insights on the Beamion LUNG-1 clinical trial, which is investigating zongertinib in patients with advanced HER2-mutated non–small cell lung cancer.